Private Payrolls Rise 109000 in April Exceeding Expectations ADP Report Treasury Rejects Proposal to Slash VAT on Public EV Charging Sources Say Taco Johns Expands Fargo Footprint with Second Location AIPowered RealTime Feedback Reshapes Customer Experience Analytics Market Viatris Inc Analysts Weigh PostMerger Strategy and Generic Drug Portfolio Outlook Bungie to End Major Content Updates for Destiny 2 Game Remains Playable After Final Patch CRH Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Resilience Daktronics DAKT Q1 2026 Earnings EPS Misses Estimates Amid Supply Chain Headwinds Yet Stock Gains BTG Q1 2026 Earnings EPS Surges Past Estimates by 43 Yet Stock Declines Banco Macro SA BMA Q4 2025 Earnings Strong EPS Beat Overshadowed by Broader Market Headwinds Magna International Inc MGA Q1 2026 Earnings EPS Blows Past Estimates Stock Gains 236 CHCT Q1 2026 Earnings EPS Soars Past Estimates with 449 Surprise Eagle Point Credit Co Notes Hold Steady Near 2516 Amid Tight Trading Range ECCW Pimco Global StocksPlus Income Fund PGP Edges Higher in Modest Uptick as IncomeFocused Investors Return Cohen Steers Limited Duration Preferred and Income Fund LDP Holds Steady Above Key Support Mirum Pharmaceuticals MIRM Faces Slight Pullback Support Levels Tested Muzero Acquisition Corp Unit MUZEU Holds Steady at 1003 as SPAC Unit Trades in Tight Range European Manufacturers Expand China Operations Amid EU Derisking Efforts Mosaic Company MOS Q1 2026 Earnings EPS Falls Short by 79 Stock Rises Unexpectedly TriSalus Life Sciences TLSI Falls Over 5 as Stock Tests Key Support Near 310 ENGNW Warrants Slip 385 to 025 as Trading Narrows Near Support Terrestrial Energy Warrants Surge Over 10 as Nuclear Energy Sentiment Heats Up ICU Medical Inc ICUI Rises Modestly as Technicals Suggest RangeBound Trading CNS Pharmaceuticals CNSP Faces Selling Pressure as Shares Decline Over 5 3 E Network Technology Group MASK Gains 457 as Stock Tests Key Resistance Spectral AI Inc Warrants MDAIW Surge on Renewed Interest Key Levels in Focus Atara Biotherapeutics ATRA Faces Selling Pressure Near Key Resistance Zone